CAPTRUST Financial Advisors
PRAH

CAPTRUST Financial Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,491
Closed -$1.73M – 4926
2021
Q2 		$1.73M Sell
10,491
-6,690
-39% -$1.12M 0.02% 539
2021
Q1 		$2.63M Sell
17,181
-178,514
-91% -$24.2M 0.03% 404
2020
Q4 		$24.5M Buy
195,695
+53,418
+38% +$5.97M 0.33% 80
2020
Q3 		$15M Sell
142,277
-24,891
-15% -$2.54M 0.25% 106
2020
Q2 		$15.9M Sell
167,168
-5,665
-3% -$527K 0.26% 103
2020
Q1 		$13.2M Buy
172,833
+2,709
+2% +$264K 0.29% 96
2019
Q4 		$18.7M Buy
+170,124
New +$17.5M 0.3% 90

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

CAPTRUST Financial Advisors's PRAH Position: Q3 2021 in Review

CAPTRUST Financial Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 10,491 shares — an estimated $1.73M sold.

CAPTRUST Financial Advisors first reported a position in PRAH in Q4 2019 and held it in 7 quarters. The position peaked at $24.5M in Q4 2020. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • CAPTRUST Financial Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 10,491 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.73M.
  • CAPTRUST Financial Advisors first reported a position in PRA Health Sciences, Inc. in Q4 2019 and held it in 7 quarters.
  • CAPTRUST Financial Advisors's PRA Health Sciences, Inc. position peaked at $24.5M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.